Top View
- Endothelin Promotes Colorectal Tumorigenesis by Activating YAP/TAZ
- Role of Endothelin Axis in Pancreatic Tumor Microenvironment
- Endothelin ETA Receptor Blockade, by Activating ETB Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention S
- Systematic Identification of Non-Coding Pharmacogenomic
- Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
- Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
- WO 2018/005695 Al O
- Physiologist Physiologist
- Endothelin a Receptor/B-Arrestin Signaling to the Wnt Pathway Renders Ovarian Cancer Cells Resistant to Chemotherapy
- ETBR Antagonist)
- Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole
- Pharmacology and Toxicology
- SWEENEY-DISSERTATION-2020.Pdf
- WO 2013/188138 Al 19 December 2013 (19.12.2013) P O P C T
- Pharmaabkommen A1 E
- Data-Driven and Knowledge-Driven Computational Models of Angiogenesis in Application to Peripheral Arterial Disease
- Clinical Trials with Endothelin Receptor Antagonists: What Went Wrong and Where Can We Improve?☆
- Astrazeneca Annual Report and Form 20-F Information 2009 Contact Information Health in the Real World
- Bioactive Compound Library Plus (96-Well)
- U.S. Pharmaceutical/Biotech Industry Update
- Cerebrovascular Disease in Ageing and Alzheimer's Disease
- TABLE S2 Manic El Al.Xlsx
- Macitentan, a Dual Endothelin Receptor Antagonist, In
- Full-Year 2020 Results Clinical Trials Appendix PDF 2537KB
- (ZD4054) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
- Pirfenidone, an Anti-Fibrotic Drug, Suppresses the Growth of Human Prostate Cancer Cells by Inducing G1 Cell Cycle Arrest
- WO 2016/133803 Al 25 August 2016 (25.08.2016) P O P C T
- Tumor Endothelin-1 Enhances Metastatic Colonization of the Lung in Mouse Xenograft Models of Bladder Cancer
- Endothelin Receptor
- Side Effect Profiles
- Management of Advanced and Castration Resistant Prostate Cancer
- Development and Implementation of the SUM Breast Cancer Cell Line Functional Genomics Knowledge Base ✉ Stephen P
- Fibroblasts Prolong Serum Prostate-Specific Antigen Decline
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Adooq Bioscience Kinase Inhibitors Catalog 2014-2015
- Β-Arrestin-1 Is a Nuclear Transcriptional Regulator of Endothelin-1-Induced
- GRP94 Rewires and Buffers the FLT3-ITD Signaling Network And
- WO 2018/020238 Al 01 February 2018 (01.02.2018) W !P O PCT
- ZD4054 (Zibotentan)
- Tepzz 5 58¥Zb T
- Compositions for Treating Breast Cancer
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Overcoming Drug Resistance and Treating Advanced Prostate Cancer
- Metastatic Hormone-Relapsed Prostate Cancer [ID1359]
- Standouts Melanoma Drug Yervoy, with Seemingly Better Tolerability
- Endocrinology
- ZD4054) in Colorectal Cancer: a Preclinical Study
- Anti-Endothelin Drugs in Solid Tumors
- Molnova Product 2020
- WO 2017/106630 Al 22 June 2017 (22.06.2017) W P O P C T
- (12) Patent Application Publication (10) Pub. No.: US 2013/0310407 A1 Regenass (43) Pub
- Pharmacokinetics and Tolerability of Zibotentan (ZD4054) in Subjects with Hepatic Or Renal Impairment: Two Open-Label Comparativ
- Evidence-Based Oncology